Back to Search
ROBERT CRESCENTINI, M.D.
M.D.
Medical Oncology Physician
NPI: 1609079797IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
ME107896(FL)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
ME107896(FL)
Education
OTHER
Class of 2007
Research & Publications (8)
Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice.
PMID 14746921·Brain Res·2004
7-preclinical
Behavioral effects of CD40-CD40L pathway disruption in aged PSAPP mice.
PMID 15223380·Brain Res·2004
4-observational
Increased TNFalpha production and Cox-2 activity in organotypic brain slice cultures from APPsw transgenic mice.
PMID 14642439·Neurosci Lett·2003
4-observational
Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation.
PMID 14503019·Neurol Res·2003
7-preclinical
p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
PMID 12125077·J Neurosci Res·2002
7-preclinical
Confirmation of association between D10S583 and Alzheimer's disease in a case--control sample.
PMID 12044628·Neurosci Lett·2002
8-other
Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice.
PMID 12402041·Nat Neurosci·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3001 W DR MARTIN LUTHER KING JR BLVD
TAMPA, FL 33607 - Phone
- (813) 321-6589
Quick Facts
- NPI
- 1609079797
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 19
- Publications
- 8
Are you this provider?
Claim Your Profile